Skip to main content

Visual drifting

perception effect

valencecontext-dependentfrequencyuniversaltemporalacute

AI-inferred — this entry was drafted by AI and has not yet been verified against primary sources. A sourced revision is planned.

Visual drifting is a perceptual distortion in which stationary surfaces, objects, and textures appear to slowly shift, breathe, or flow.

As a drug effect it is acute and dose-proportional, fading as the substance wears off; it is distinct from any standing visual disorder. It ranges from a barely perceptible shimmer at low doses to pronounced, continuous movement of whole scenes at high ones.

Visual drifting is among the most universally reported perceptual effects across psychoactive substances. It is most commonly induced at moderate to high doses under psychedelics such as LSD, psilocybin mushrooms, and DMT, and under dissociatives such as ketamine and dextromethorphan; it also appears under stimulants such as methamphetamine and A-PHP, and under depressants including GHB and eszopiclone.

phenomenology

Visual drifting is felt as a slow, organic movement of surfaces the mind knows to be still: walls appear to breathe, floor patterns slide, text shifts on the page.

The motion tends to follow an undulating rhythm rather than a jitter, and is especially pronounced along high-contrast edges and fine-grained textures. Attending directly to a drifting surface tends to intensify it, drawing the gaze in.

At higher doses, particularly under psychedelics and dissociatives, the movement grows more fluid and can encompass the entire visual field at once.

mechanism

Visual drifting arises through different pathways depending on the drug class:

  • Psychedelics — act at 5-HT2A receptors in visual cortex, disrupting the predictive processing that normally suppresses motion noise; top-down suppression breaks down and surfaces begin to drift.
  • Dissociatives — block NMDA receptors, destabilizing sensory gating and producing similar cortical disinhibition of the visual system.
  • Stimulants — at high doses, dopaminergic and noradrenergic overactivation generates mild visual instability and drifting.
  • Depressants — GABAergic enhancement alters visual processing in a dose-dependent way, with drifting appearing at sedating doses.

How much each pathway contributes in a given case is not fully understood.

variability

Who experiences it, and how strongly, varies widely. Higher doses increase both likelihood and intensity; at low doses drifting may be absent entirely. Visual surroundings play an outsized role — environments rich in fine texture, repetitive pattern, or ambient movement tend to amplify it — especially under psychedelics and dissociatives.

Prior history with psychedelics can lower the threshold, making drifting accessible at doses where it would not otherwise appear. Expectation also shapes it: directing attention at a surface in anticipation of movement tends to be self-fulfilling.